A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States

This study tracks how a device called TAR-200 is being used in real life to treat a type of bladder cancer that hasn't grown into the bladder muscle (non-muscle invasive bladder cancer, or NMIBC). TAR-200 is a small device placed inside the bladder that slowly releases chemotherapy. Researchers want to understand how it performs outside of clinical trials. **You may be eligible if...** - You have been diagnosed with non-muscle invasive bladder cancer - You have already started using TAR-200 within the past 6 weeks - You are willing to follow contraceptive guidelines if you are able to become pregnant **You may NOT be eligible if...** - You have not yet started TAR-200 treatment - You are unwilling to follow the study's requirements Talk to your doctor to see if this trial is right for you.